Comparable attenuation of sympathetic nervous system activity in obese subjects with normal glucose tolerance, impaired glucose tolerance, and treatment Naïve type 2 diabetes following equivalent weight loss

Frontiers in Physiology

Volumn 7, Issue NOV, 2016, Pages

  Straznicky, Nora E ^a   Grima, Mariee T ^a   Sari, Carolina I ^a   Lambert, Elisabeth A ^a,b,c   Phillips, Sarah E ^a   Eikelis, Nina ^a   Mariani, Justin A ^a,b   Kobayashi, Daisuke ^a   Hering, Dagmara ^a   Dixon, John B ^a,b   Lambert, Gavin W ^a,b  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Glucose tolerance; Hyperinsulinemia; Hypocaloric diet; Obesity; Sympathetic nervous system; Type 2 diabetes; Weight loss

Indexed keywords

C REACTIVE PROTEIN; LEPTIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NORADRENALIN; TRIACYLGLYCEROL;

ADRENERGIC SYSTEM; ADULT; AGE; AREA UNDER THE CURVE; ARTICLE; BLOOD CHEMISTRY; BODY MASS; CARBOHYDRATE DIET; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULINOGENIC INDEX; LIPID DIET; LOW CALORY DIET; MALE; MUSCLE SYMPATHETIC NERVE ACTIVITY; NERVOUS SYSTEM FUNCTION; NEUROGRAPHY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PRESSORECEPTOR REFLEX; PROTEIN BLOOD LEVEL; PROTEIN DIET; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; WEIGHT CHANGE; WEIGHT REDUCTION;

EID: 85006437105     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2016.00516     Document Type: Article

References (56)

1. Alvarez, G. E., Beske, S. D., Ballard, T. P., and Davy, K. P. (2002). Sympathetic neural activation in visceral obesity. Circulation 106, 2533-2536. doi: 10.1161/01.CIR.0000041244.79165.25
2. Anderson, E. A., Hoffman, R. P., Balon, T. W., Sinkey, C. A., and Mark, A. L. (1991). Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans. J. Clin. Invest. 87, 2246-2252. doi: 10.1172/JCI115260
3. Appel, L. J., Moore, T. J., Obarzanek, E., Vollmer, W. M., Svetkey, L. P., Sacks, F. M., et al. (1997). A clinical trial of the effects of dietary patterns on blood pressure. N. Engl. J. Med. 336, 1117-1124. doi: 10.1056/NEJM199704173361601
4. Bigornia, S. J., Farb, M. G., Tiwari, S., Karki, S., Hamburg, N. M., Vita, J. A., et al. (2013). Insulin status and vascular responses to weight loss in obesity. J. Am. Coll. Cardiol. 62, 2297-2305. doi: 10.1016/j.jacc.2013.07.078
5. Bray, G. A. (1990). Obesity-A state of reduced sympathetic activity and normal or high adrenal activity (The autonomic and adrenal hypothesis revisited). Int. J. Obesity 14(Suppl. 3), 77-92
6. Casellini, C. M., Parson, H. K., Hodges, K., Edwards, J. F., Lieb, D. C., Wohlgemuth, S. D., et al. (2016). Bariatric surgery restores cardiac and sudomotor autonomic C-fiber dysfunction towards normal in obese subjects with type 2 diabetes. PLoS ONE 11:e0154211. doi: 10.1371/journal.pone.0154211
7. deJonge, L., Moreira, E. A. M., Martin, C. K., and Ravussin, E. (2010). Impact of six-month caloric restriction on autonomic nervous system activity in healthy, overweight, individuals. Obesity 18, 414-416. doi: 10.1038/oby.2009.408
8. Eikelis, N., Schlaich, M., Aggarwal, A., Kaye, D., and Esler, M. (2003). Interactions between leptin and the human sympathetic nervous system. Hypertension 41, 1072-1079. doi: 10.1161/01.HYP.0000066289.17754.49
9. Esler, M., Jackman, G., Bobik, A., Kelleher, D., Jennings, G., Leonard, P., et al. (1979). Determination of norepinephrine apparent release rate and clearance in humans. Life Sci. 25, 1461-1470. doi: 10.1016/0024-3205(79)90371-0
10. Flaa, A., Aksnes, T. A., Kjeldsen, S. E., Eide, I., and Rostrup, M. (2008). Increased sympathetic reactivity may predict insulin resistance: an 18-year follow-up study. Metabolism 57, 1422-1427. doi: 10.1016/j.metabol.2008.05.012
11. Gerritsen, J., Dekker, J. M., TenVoorde, B. J., Bertelsmann, F. W., Kostense, P. J., Stehouwer, C. D. A., et al. (2000). Glucose tolerance and other determinants of cardiovascular autonomic function: the Hoorn Study. Diabetologia 43, 561-570. doi: 10.1007/s001250051344
12. Grassi, G. (2001). Renin-angiotensin-sympathetic crosstalks in hypertension: reappraising the relevance of peripheral interactions. J. Hypertens. 19, 1713-1716. doi: 10.1097/00004872-200110000-00003
13. Grassi, G., Dell'Oro, R., Facchini, A., Trevano, F. Q., Bolla, G. B., and Mancia, G. (2004). Effect of central and peripheral body fat distribution on sympathetic and baroreflex function in obese normotensives. J. Hypertens. 22, 2363-2369
14. Grassi, G., Dell'Oro, R., Quarti-Trevano, F., Scopelliti, F., Servalle, G., Paleari, F., et al. (2005). Neuroadrenergic and reflex abnormalities in patients with metabolic syndrome. Diabetologia 48, 1359-1365. doi: 10.1007/s00125-005-1798-z
15. Huggett, R. J., Scott, E. M., Gilbey, S. G., Stoker, J. B., Mackintosh, A. F., and Mary, D. A. (2003). Impact of type 2 diabetes mellitus on sympathetic neural mechanisms in hypertension. Circulation 108, 3097-3101. doi: 10.1161/01.CIR.0000103123.66264.FE
16. Huggett, R. J., Hogarth, A. J., Mackintosh, A. F., and Mary, D. A. (2006). Sympathetic nerve hyperactivity in non-diabetic offspring of patients with type 2 diabetes. Diabetologia 49, 2741-2744. doi: 10.1007/s00125-006-0399-9
17. Inzucchi, S. E., Bergenstal, R. M., Buse, J. B., Diamant, M., Ferrannini, E., Nauck, M., et al. (2012). Management of hyperglycaemia in type 2 diabetes: a patient-centred approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia 55, 1577-1596. doi: 10.1007/s00125-012-2534-0
18. Jennings, G., Nelson, L., Nestel, P., Esler, M., Korner, P., Burton, D., et al. (1986). The effects of changes in physical activity on major cardiovascular risk factors, hemodynamics, sympathetic function, and glucose utilization in man: a controlled study of four levels of exercise. Circulation 73, 30-40. doi: 10.1161/01.CIR.73.1.30
19. Julius, S., Valentini, M., and Palatini, P. (2000). Overweight and hypertension: a 2-way street? Hypertension 35, 807-813. doi: 10.1161/01.HYP.35.3.807
20. Kaiyala, K. J., Prigeon, R. L., Kahn, S. E., Woods, S. C., and Schwartz, M. W. (2000). Obesity induced by a high-fat diet is associated with reduced brain insulin transport in dogs. Diabetes 49, 1525-1533. doi: 10.2337/diabetes.49.9.1525
21. Kim, J., Montagnani, M., Koh, K. K., and Quon, M. J. (2006). Reciprocal relationship between insulin resistance and endothelial dysfunction. Molecular and pathophysiological mechanisms. Circulation 113, 1888-1904. doi: 10.1161/CIRCULATIONAHA.105.563213
22. Lambert, G. W., Straznicky, N. E., Lambert, E. A., Dixon, J. B., and Schlaich, M. P. (2010). Sympathetic nervous activation in obesity and the metabolic syndrome-Causes, consequences and therapeutic implications. Pharmacol. Ther. 126, 159-172. doi: 10.1016/j.pharmthera.2010.02.002
23. Lambert, E. A., Straznicky, N., Sari, C. I., Eikelis, N., Hering, D., Head, G., et al. (2013). Dyslipidemia is associated with sympathetic nervous activation and impaired endothelial function in young females. Am. J. Hypertens. 26, 250-256. doi: 10.1093/ajh/hps016
24. Layman, D. K., Boileua, R. A., Erickson, D. J., Painter, J. E., Shiue, H., Sather, C., et al. (2003). A reduced ratio of dietary carbohydrate to protein improves body composition and blood lipid profiles during weight loss in adult women. J. Nutr. 133, 411-417
25. Lee, Z. S., Critchley, J. A., Tomlinson, B., Young, R. P., Thomas, G. N., Cockram, C. S., et al. (2001). Urinary epinephrine and norepinephrine interrelations with obesity, insulin, and the metabolic syndrome in Hong Kong Chinese. Metabolism 50, 135-143. doi: 10.1053/meta.2001.19502
26. Lien, L. F., Brown, A. J., Ard, J. D., Loria, C., Erlinger, T. P., Feldstein, A. C., et al. (2007). Effects of PREMIER lifestyle modifications on participants with and without the metabolic syndrome. Hypertension 50, 609-616. doi: 10.1161/HYPERTENSIONAHA.107.089458
27. Machleidt, F., Simon, P., Krapalis, A. F., Hallschmid, M., Lehnert, H., and Sayk, F. (2013). Experimental hyperleptinemia acutely increases vasoconstrictory sympathetic nerve activity in healthy humans. J. Clin. Endocrinol. Metab. 98, E491-E496. doi: 10.1210/jc.2012-3009
28. Mackintosh, R. M., and Hirsch, J. (2001). The effects of leptin administration in non-obese human subjects. Obes. Res. 9, 462-469. doi: 10.1038/oby.2001.60
29. Mark, A. L. (2013). Selective leptin resistance revisited. Am. J. Physiol. Regul. Integr. Comp. Physiol. 305, R566-R581. doi: 10.1152/ajpregu.00180.2013
30. Masuo, K., Kawaguchi, H., Mikami, H., Ogihara, T., and Tuck, M. L. (2003). Serum uric acid and plasma norepinephrine concentrations predict subsequent weight gain and blood pressure elevation. Hypertension 42, 474-480. doi: 10.1161/01.HYP.0000091371.53502.D3
31. Matsuda, M., and DeFronzo, R. A. (1999). Insulin sensitivity indices obtained from oral glucose tolerance testing. Diabetes Care 22, 1462-1470. doi: 10.2337/diacare.22.9.1462
32. Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., and Turner, R. C. (1985). Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412-419. doi: 10.1007/BF00280883
33. Ozata, M., Ozdemir, I. C., and Licinio, J. (1999). Human leptin deficiency caused by a missense mutation: multiple endocrine defects, decreased sympathetic tone, and immune system dysfunction indicate new targets for leptin action, greater central than peripheral resistance to the effects of leptin, and spontaneous correction of leptin-mediated defects. J. Clin. Endocrinol. Metab. 84, 3686-3695. doi: 10.1210/jcem.84.10.5999
34. Parati, G., Saul, J. P., and Castiglioni, P. (2004). Assessing arterial baroreflex control of heart rate: new perspectives. J. Hypertens. 22, 1259-1263. doi: 10.1097/01.hjh.0000125469.35523.32
35. Pricher, M. P., Freeman, K. L., and Brooks, V. L. (2008). Insulin in the brain increases gain of baroreflex control of heart rate and lumbar sympathetic nerve activity. Hypertension 51, 514-520. doi: 10.1161/HYPERTENSIONAHA.107.102608
36. Rahmouni, K., Haynes, W. G., Morgan, D. A., and Mark, A. L. (2003). Role of melanocortin-4 receptors in mediating renal sympathoactivation to leptin and insulin. J. Neurosci. 23, 5998-6004
37. Rahmouni, K., Morgan, D. A., Morgan, G. M., Liu, X., Sigmund, C. D., Mark, A. L., et al. (2004). Hypothalamic PI3K and MAPK differentially mediate regional sympathetic activation to insulin. J. Clin. Invest. 114, 652-658. doi: 10.1172/JCI21737
38. Schlaich, M. P., Grassi, G., Lambert, G. W., Straznicky, N., Esler, M. D., Dixon, J., et al. (2009). European society of hypertension working group on obesity. Obesity-induced hypertension and target organ damage: current knowledge and future directions. J. Hypertens. 27, 207-211. doi: 10.1097/HJH.0b013e32831dafaf
39. Sjostrom, L., Peltonen, M., Jacobson, P., Sjöström, C. D., Karason, K., Wedel, H., et al. (2012). Bariatric surgery and long-term cardiovascular events. JAMA 307, 56-65. doi: 10.1001/jama.2011.1914
40. Snitker, S., MacDonald, I., Ravussin, E., and Astrup, A. (2000). The sympathetic nervous system and obesity: role in aetiology and treatment. Obesity Rev. 1, 5-15. doi: 10.1046/j.1467-789x.2000.00001.x
41. Solomon, T. P., Haus, J. M., Kelly, K. R., Rocco, M., Kashyap, S. R., and Kirwan, J. P. (2010). Improved pancreatic β-cell function in type 2 diabetic patients after lifestyle-induced weight loss is related to glucose-dependent insulinotropic polypeptide. Diabetes Care 33, 1561-1566. doi: 10.2337/dc09-2021
42. Straznicky, N. E., Lambert, E. A., Lambert, G. W., Masuo, K., Esler, D. M., and Nestel, P. J. (2005). Effects of dietary weight loss on sympathetic activity and cardiovascular risk factors associated with the metabolic syndrome. J. Clin. Endocrinol. Metab. 90, 5998-6005. doi: 10.1210/jc.2005-0961
43. Straznicky, N. E., Lambert, E. A., Nestel, P. J., McGrane, M., Dawood, T., Schlaich, M., et al. (2010). Sympathetic neural adaptation to hypocaloric diet with or without exercise training in obese metabolic syndrome subjects. Diabetes 59, 71-79. doi: 10.2337/db09-0934
44. Straznicky, N. E., Lambert, E. A., Grima, M. T., Eikelis, N., Rischards, K., Nestel, P. J., et al. (2014). The effects of dietary weight loss on indices of norepinephrine turnover: modulatory influence of hyperinsulinemia. Obesity 22, 652-662. doi: 10.1002/oby.20614
45. Tataranni, P. A., Young, J. B., Bogardus, C., and Ravussin, E. (1997). A low sympathoadrenal activity is associated with body weight gain and development of central adiposity in Pima Indian men. Obes. Res. 5, 341-347. doi: 10.1002/j.1550-8528.1997.tb00562.x
46. Vallbo, A. B., Hagbarth, K. E., and Wallin, B. G. (2004). Microneurography: how the technique developed and its role in the investigation of the sympathetic nervous system. J. App. Physiol. 96, 1262-1269. doi: 10.1152/japplphysiol.00470.2003
47. Vaz, M., Jennings, G., Turner, A., Cox, H., Lambert, G., and Esler, M. (1997). Regional sympathetic nervous activity and oxygen consumption in obese normotensive human subjects. Circulation 96, 3423-3429. doi: 10.1161/01.CIR.96.10.3423
48. Vollenweider, P., Randin, D., Tappy, L., Jéquier, E., Nicod, P., and Scherrer, U. (1994). Impaired insulin-induced sympathetic neural activation and vasodilation in skeletal muscle in obese humans. J. Clin. Invest. 93, 2365-2371. doi: 10.1172/JCI117242
49. Watkins, L. L., Surwit, R. S., Grossman, P., and Sherwood, A. (2000). Is there a glycemic threshold for impaired autonomic control? Diabetes Care 23, 826-830. doi: 10.2337/diacare.23.6.826
50. Wu, J. S., Lu, F. H., Yang, Y. C., Chang, S. H., Huang, Y. H., Chen, J. J., et al. (2014). Impaired baroreflex sensitivity in subjects with impaired glucose tolerance, but not isolated impaired fasting glucose. Acta Diabetol. 51, 535-541. doi: 10.1007/s00592-013-0548-9
51. Wulsin, L. R., Horn, P. S., Perry, J. L., Massaro, J., and D'Agostino, R. (2015). Autonomic imbalance as a predictor of metabolic risks, cardiovascular disease, diabetes, and mortality. J. Clin. Endocrinol. Metab. 100, 2443-2448. doi: 10.1210/jc.2015-1748
52. Young, C. N., Deo, S. H., Chaudhary, K., Thyfault, J. P., and Fadel, P. J. (2010). Insulin enhances the gain of arterial baroreflex control of muscle sympathetic nerve activity in humans. J. Physiol. 588, 3593-3603. doi: 10.1113/jphysiol.2010.191866
53. World Health Organization (2006). Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycemia: Report of a WHO/IDF Consultation. Geneva
54. Prospective Studies Collaboration (2009). Body-mass index and cause-specific mortality in 900,000 adults: collaborative analyses of 57 prospective studies. Lancet 373, 1083-1096. doi: 10.1016/S0140-6736(09)60318-4
55. Australian Bureau of Statistics (2015). National Health Survey: First Results Australia 2014-15. Canberra: ABS 2015 (ABS Catalogue No. 4364.0.55.001)
56. Yufu, K., Okada, N., Ebata, Y., Murozono, Y., Shinohara, T., Nakagawa, M., et al. (2014). Plasma norepinephrine is an independent predictor of adverse cerebral and cardiovascular events in type 2 diabetic patients without structural heart disease. J. Cardiol. 64, 225-230. doi: 10.1016/j.jjcc.2013.12.009